LabTurbo Biotech (ROCO:7725) Stock Based Compensation: NT$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7725 LabTurbo Biotech Corp ROCO:7725
12 GF Score
Price NT$22.80
! 3 Warning Signs
View Full Analysis

What is LabTurbo Biotech Stock Based Compensation?

LabTurbo Biotech ROCO:7725 12 Stock Based Compensation is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:7725 with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

LabTurbo Biotech's Stock Based Compensation for the six months ended in Dec. 2025 was NT$0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.00 Mil.


LabTurbo Biotech Stock Based Compensation Related Terms


LabTurbo Biotech Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for LabTurbo Biotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LabTurbo Biotech Stock Based Compensation Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
0.21 0.00 0.00 0.00 0.00

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7725
12GF Score
LabTurbo Biotech Corp ROCO:7725
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LabTurbo Biotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

What does a Stock Based Compensation of NT$0.00 Mil mean?
LabTurbo Biotech (ROCO:7725) has a Stock Based Compensation of NT$0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LabTurbo Biotech and its competitors.
Is LabTurbo Biotech's Stock Based Compensation too high?
LabTurbo Biotech's current Stock Based Compensation is NT$0.00 Mil. Overall, LabTurbo Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does LabTurbo Biotech's Stock Based Compensation compare to VRTX and REGN?
LabTurbo Biotech's Stock Based Compensation of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Biotechnology company?
A good Stock Based Compensation depends on the Biotechnology industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for LabTurbo Biotech and its competitors. LabTurbo Biotech's current Stock Based Compensation is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LabTurbo Biotech stock overvalued right now?
LabTurbo Biotech (ROCO:7725) has a current Stock Based Compensation of NT$0.00 Mil. The current Stock Based Compensation is NT$0.00 Mil. LabTurbo Biotech's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For LabTurbo Biotech (ROCO:7725), the current Stock Based Compensation is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LabTurbo Biotech Business Description

Address 3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.
12GF Score

Get the complete analysis for ROCO:7725

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.80
Price